These authors contributed equally to the study.
Autoimmune, Cholestatic and Biliary Disease
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis
Version of Record online: 1 APR 2014
© 2014 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Volume 59, Issue 5, pages 1954–1963, May 2014
How to Cite
Boonstra, K., Culver, E. L., de Buy Wenniger, L. M., van Heerde, M. J., van Erpecum, K. J., Poen, A. C., van Nieuwkerk, K. M.J., Spanier, B.W. M., Witteman, B. J.M., Tuynman, H. A.R.E., van Geloven, N., van Buuren, H., Chapman, R. W., Barnes, E., Beuers, U. and Ponsioen, C. Y. (2014), Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology, 59: 1954–1963. doi: 10.1002/hep.26977
Potential conflict of interest: Dr. Ponsioen received grants from Tramedico, Dr. Falk, and Zambon.
This research was supported by a Ph.D. fellowship of the Academic Medical Center Amsterdam (to L.M.W.), a Wellcome Trust Fellowship grant (095160/Z/10/Z; to E.C.), a Senior Clinician Scientist funding by the Medical Research Council, UK (to E.B.), grants “Primary sclerosing cholangitis” by the Deutsche Crohn und Colitis Vereinigung (DCCV) and the Norwegian Primary Sclerosing Cholangitis (NoPSC) Foundation (to U.B.), and unrestricted grants from AbbVie Inc., the Netherlands, Tramedico Inc., the Netherlands, Dr. Falk Pharma Benelux Inc., and Zambon Inc., the Netherlands (to C.P.).
The copyright line in this article was changed on 5 February 2015 after original online publication.
- Issue online: 23 APR 2014
- Version of Record online: 1 APR 2014
- Accepted manuscript online: 21 DEC 2013 12:25AM EST
- Manuscript Accepted: 17 DEC 2013
- Manuscript Received: 20 MAY 2013
- 19Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006;101:2070–2075., , , , , , et al.Direct Link:
- 23Primary sclerosing cholangitis associated with elevated immunoglobulin-g4: a preliminary study. ISRN Gastroenterol 2012;2012:32574., , , , .
- 26R development core team. R: a language and environment for statistical computing [Internet]. Vienna: 2011. Available at: www.r-project.org/. Accessed December 2012.